Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 11Genitourinary 8Gastrointestinal 8Head & Neck 5Breast 4Gynecologic 3Tumor-Agnostic 2Other hematologic neoplasm 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1Myeloid 1Lymphoid 1

Conditions

Melanoma 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 69Nivolumab 57Ipilimumab 36Specimen Handling 32Magnetic Resonance Spectroscopy 25Cyclophosphamide 23Biopsy 18cemiplimab 14fludarabine 13relatlimab 11binimetinib 11Opdualag 11CTLA-4 Antigen 11trametinib 10fludarabine phosphate 10Radiosurgery 10avelumab 9Radiotherapy 9lifileucel 8dabrafenib 8Blood Specimen Collection 8atezolizumab 7aldesleukin 7Paclitaxel 7encorafenib 6X-Rays 6Standard of Care 6Interleukin-2 6Immunoglobulin G 6HhAntag691 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observation × Dermatologic × 90 days × Clear all
NCT07621614 2026-06-05

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Children's Oncology Group

Phase NA Not yet recruiting
51 enrolled
Dermatologic

Melanoma

NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

University of Michigan Rogel Cancer Center

Phase NA Recruiting
200 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡